Utilizing this regimen, pre-treatment with the Nrf2 activator cinnamaldehyde one week before the administration of AOM, and thereafter maintained throughout DSS exposure, resulted in the number of colon tumours being reduced to approx. 50% in wildtype mice but no such reduction was observed in Nrf2-ko mice [96]. The gene discussed is NFE2L2; the disease is infectious otitis media.